169303 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
COMPOSITIONS AND METHODS FOR TREATING ATRIAL FIBRILLATION
#302PPARy AGONIST FOR TREATMENT OF PROGRESSIVE SUPRANUCLEAR PALSY
#303Protease and Binding Polypeptide for O-Glycoproteins
#304SYSTEMS AND METHODS FOR BIOMOLECULE PREPARATION
#305ANTI-ABCG2 ANTIBODIES AND USES THEREOF
#306Fibronectin-Binding Peptides for Use in Tumor or Fibrosis Diagnosis and Therapy
#307Conjugate comprising an active MMP-9-binding peptide
#308COMPOUNDS FOR THE DETECTION OF GLYCANS
#309Rapid Assay Methods and Kits for Detecting Neutralizing Antibody for Sars-Cov-2 Using Lateral Flow Assay and Enzyme-linked Immunosorbent Assay
#310Compound Fixing Method, Detection Method, Screening Method, Substrate Used in Same, Compound Fixing Agent, and Fixing Kit
#311NANOPORE PREPARATION AND DETECTION METHOD AND DETECTION APPARATUS THEREOF
#312METHOD FOR RECOVERING EXTRACELLULAR VESICLES
#313FIBRONECTIN BINDING DOMAINS WITH REDUCED IMMUNOGENICITY
#314PD-1 VARIANTS HAVING INCREASED PD-L1 AFFINITY
#315METHOD
#316MATERIALS AND METHODS FOR HINGE REGIONS IN FUNCTIONAL EXOGENOUS RECEPTORS
#317SYSTEM AND METHOD FOR TESTING BIOLOGICAL SAMPLES
#318Aminothiolester compounds or pharmaceutically acceptable salts thereof, for use for the treatment of cancer
#319CD8A-binding fibronectin type III domains
#320Photo-cleavable surfactants
#321SERUM METABOLITES AS BIOMARKERS FOR CARNITINE TREATMENT OF SEPSIS
#322MONOCLONAL ANTIBODIES TARGETING HSP70 AND THERAPEUTIC USES THEREOF
#323Neurokinin antagonists and uses thereof
#324COMPOSITION USING URINE SAMPLE FOR DIAGNOSIS OF KIDNEY DISEASE
#325SGEF CONTROLS MACULAR, CORPUS CALLOSUM AND HIPPOCAMPAL FUNCTION AND DEVELOPMENT, LIVER HOMEOSTASIS, FUNCTIONS OF THE IMMUNE SYSTEM, FEVER RESPONSE ATHEROSCLEROSIS AND TUMOROGENIC CELL GROWTH
#326SYSTEMS, METHODS, AND COMPOSITIONS TO IDENTIFY NEW PROTEIN TARGETS OF A CHEMICAL COMPOUND OR ITS DERIVATIVES
#327EDB-FN AS BIOMARKER OF CANCER AND/OR BRAIN DISEASE AND NANODRUG DELIVERY SYSTEM TARGETING SAME
#328BIENZYMATIC BIOSENSOR FOR THE DETECTION OF LACTULOSE IN BLOOD
#329PHOTOREACTIVE AND CLEAVABLE PROBES FOR TAGGING BIOMOLECULES
#330DIAGNOSTIC SYSTEM AND METHODS OF USING AND MANUFACTURING THE SAME
#331Microfluidic chip and manufacture method thereof, and cell separation and single-cell western blotting method
#332DETECTION METHOD OF CIRCULATING BMP10 (BONE MORPHOGENETIC PROTEIN 10)
#333METHODS OF DIAGNOSING AND CLASSIFYING VIRAL INFECTIONS
#334METHODS OF TREATING OR PREVENTING SERIOUS SYMPTOMS FROM COVID-19 INFECTION
#335ABDOMINAL AORTIC ANEURYSM GROWTH PROGRESSION
#336SYSTEM FOR CUMULATIVE IMAGING OF BIOLOGICAL SAMPLES
#337METHODS OF TREATING OR PREVENTING SERIOUS SYMPTOMS FROM COVID-19 INFECTION
#338MULTIPLE BIOMARKERS FOR DIAGNOSING LUNG CANCER AND USE THEREOF
#339Compositions and Methods for Enhancing Beta Cell Maturation, Health and Function
#340BIOMARKER TEST AND METHOD FOR ASSESSING MUCOSAL HEALING IN RESPONSE TO TREATMENT OF ULCERATIVE COLITIS
#341PROGNOSTIC BIOMARKER OF CANCER
#342Recombinant calprotectin
#343METHODS FOR THE ASSESSMENT OF RISK AND TREATMENTS FOR LIVER CANCERS AND LETHAL LIVER DISEASE COMPLICATIONS
#344Uses of 5-Aminovaleric Acid Betaine and Compositions Related Thereto
#345Apparatus and method of analyzing developed impact marks, and computer program for executing the method
#346INTER-ALPHA INHIBITOR PROTEINS
#347PEPTIDE-MHC COMPLEXES
#348QUANTITATIVE KIT FOR MYXOVIRUS RESISTANCE PROTEIN 1
#349METHOD FOR DETECTING PROTEIN IN EXTRACELLULAR VESICLES AND EXTRACELLULAR VESICLE MEMBRANE PERMEABILIZATION TREATMENT AGENT
#350PROCESS TO IDENTIFY CONSORTIA OF PROBIOTIC STRAINS SUITABLE FOR GLUTEN DEGRADATION
#351Methods for Determining Lymphocyte Receptor Chain Pairs
#352Protein and Peptide Fingerprinting and Sequencing by Nanopore Translocation of Peptide-Oligonucleotide Complexes
#353ANTIBODY MOLECULES TO CD73 AND USES THEREOF
#354METHODS FOR TREATING MUSCULAR DYSTROPHY
#355NOVEL METHODS FOR EARLY IDENTIFICATION OF BONE HEALING ABILITY IN INJURED PATIENTS
#356AN ACCURATE AND COMPREHENSIVE CARDIAC TROPONIN I ASSAY ENABLED BY NANOTECHNOLOGY AND PROTEOMICS
#357METHOD FOR IDENTIFYING AND TREATING STREPTOCOCCUS PYOGENES INFECTION
#358Rapid assay for detection of SARS-CoV-2 antibodies
#359NEUROFILAMENT LIGHT CHAIN (NFL) AS A BIOMARKER FOR TRANSTHYRETIN AMYLOIDOSIS POLYNEUROPATHY
#360Methods for Developing Personalized Drug Treatment Plans and Targeted Drug Development Based on Proteomic Profiles
#361DEVICE FOR DETECTING PRESENCE OR ABSENCE OF A CHEMICAL OR BIOLOGICAL TARGET WITHIN A SAMPLE COMPRISING AN ELECTRODE FUNCTIONALISED WITH AN ANTIBODY AND CORRESPONDING DETECTION METHOD
#362METHOD FOR DETERMINING GLUCOSE CONCENTRATION IN A SERUM SAMPLE
#363Carbon Nanohorns/Nafion/Fe3O4@Pd immunosensor for Shrimp Tropomyosin
#364Insect inhibitory proteins
#365MATERIALS AND METHODS FOR INFLAMMATORY MOLECULAR MARKERS
#366Methionine concentration measurement method
#367IMPROVED TARGETED T-CELL THERAPY
#368DETERMINANTS OF CANCER RESPONSE TO IMMUNOTHERAPY
#369SEPARATED ANTIGEN AXL BINDING PROTEIN AND USE THEREOF
#370TREATMENT FOR AGE-RELATED MACULAR DEGENERATION (AMD)
#371METHODS AND USES FOR REMOTELY TRIGGERED PROTEASE ACTIVITY MEASUREMENTS
#372METHOD FOR DETECTING MICROPROTEINS IN SAMPLE SYSTEM
#373MUTANT PROTEINS AND METHODS FOR THEIR PRODUCTION
#374SARS-COV-2 RECOMBINANT RBD PROTEIN, AND PREPARATION METHOD THEREFOR
#375NON-INVASIVE PREDICTION OF RISK FOR SUDDEN CARDIAC DEATH
#376TRANSGENE GENETIC TAGS AND METHODS OF USE
#377Non-Transgenic Functional Rescue of Neuropeptides
#378Insecticidal toxin receptors and methods of use
#379Duty Cycle Improvement for a Mass Spectrometer Using Ion Mobility Separation
#380Methods for diagnosing and treating inflammatory bowel disease
#381DEFINED COMPOSITION GENE MODIFIED T-CELL PRODUCTS
#382CLAUDIN18 ANTIBODIES AND METHODS OF TREATING CANCER
#383Erythropoietin-derived peptides and methods of protecting cells from oxidative damage induced by reactive oxygen species
#384METHODS OF SCREENING FOR CONDENSATE-ASSOCIATED SPECIFICITY AND USES THEREOF
#385DIAGNOSIS OF FRONTOTEMPORAL DEMENTIA
#386HLA-H, HLA-J, HLA-L, HLA-V AND HLA-Y AS THERAPEUTIC AND DIAGNOSTIC TARGETS
#387Signature of TL1A (TNFSF15) signaling pathway
#388DEVICE AND METHODS FOR TISSUE MOLECULAR PROFILING USING ELECTROPORATION BASED MOLECULAR EXTRACTION
#389GLYCATED PROTEIN ASSAY REAGENT CONTAINING STABILIZER OF PROTEASE THAT INCREASES OXIDATION-REDUCTION POTENTIAL OF FERROCYANIDE, METHOD FOR ASSAYING GLYCATED PROTEIN, METHOD FOR PRESERVING GLYCATED PROTEIN ASSAY REAGENT, AND METHOD FOR STABILIZING GLYCATED PROTEIN ASSAY REAGENT
#390Therapeutic oligonucleotides
#391Peptide Fragment, Monoclonal Antibody, Colloidal Gold Test Strip And Detection Method Thereof Used For Detection Of Stichopus Oligopeptide
#392A METHOD FOR PREDICTING RISK OF RECURRENCE FOR EARLY-STAGE COLON CANCER BY MEASURING FOCAL ADHESION KINASE
#393PROTEINS TARGETING ORTHOLOGS
#394Nucleic acid aptamer specifically recognizing β-lactoglobulin and use thereof
#395INSECTICIDAL PROTEINS AND METHODS FOR THEIR USE
#396Methods of preparing a biofluid sample for detection of kidney injury
#397REACTION CONTAINER AND BIOCHEMICAL ANALYSIS METHOD
#398ANTI-HOG TCN1 MONOCLONAL ANTIBODIES AND METHODS OF PRODUCTION AND USE THEREOF
#399EVALUATION OF CAS9 MOLECULE/GUIDE RNA MOLECULE COMPLEXES
#400METHODS OF TREATING OR PREVENTING SPINAL MUSCULAR ATROPHY
#401PTPRS AND PROTEOGLYCANS IN AUTOIMMUNE DISEASE
#402ALLOGENEIC COMPOSITION FOR THE TREATMENT OF CNS DISORDERS
#403Apolipoprotein E isotype detection by mass spectrometry
#404CHARACTERIZATION OF PROTEIN BINDING TO PER- AND POLYFLUOROALKYL SUBSTANCES
#405MULTIPLE BIOMARKER SIMULTANEOUS ANALYSIS APPARATUS AND METHOD
#406METHOD OF IDENTIFYING INTRACELLULAR SECRETORY PROTEIN OR TISSUE-SPECIFIC SECRETORY PROTEIN
#407ANTI-CD22 ANTIBODIES AND USES THEREOF
#408COMPOSITIONS AND METHODS FOR PREDICTING LUNG FUNCTION DECLINE IN IDIOPATHIC PULMONARY FIBROSIS
#409METHOD OF EVALUATING FUNCTION OF ORGAN FOR TRANSPLANTATION, PROGRAM FOR EVALUATING FUNCTION OF ORGAN FOR TRANSPLANTATION, AND APPARATUS THAT EVALUATES FUNCTION OF ORGAN FOR TRANSPLANTATION
#410DIFFERENTIAL DETECTION OF VIRAL AND BACTERIAL INFECTIONS
#411REDUCE DISCARD OF KIDNEYS FOR TRANSPLANATION AFTER BRAIN DEATH
#412METHOD FOR ASSISTING DIAGNOSIS OF PARKINSON'S DISEASE, BIOMARKER, REAGENT KIT, AND DEVICE
#413Anti-SIRPa antibodies and their therapeutic applications
#414CHEMICALLY INDUCIBLE POLYPEPTIDE POLYMERIZATION
#415FIBRONECTIN BINDING DOMAINS WITH REDUCED IMMUNOGENICITY
#416EVALUATING METHOD FOR PHARMACOLOGICAL ACTIONS OF IMMUNE CHECKPOINT INHIBITORS, CALCULATING METHOD, EVALUATING APPARATUS, CALCULATING APPARATUS, EVALUATING PROGRAM, CALCULATING PROGRAM, RECORDING MEDIUM, EVALUATING SYSTEM, AND TERMINAL APPARATUS
#417Miniaturized antibody of anti-glucocorticoid-induced tumor necrosis factor receptor (GITR), and polymer and use thereof
#418Doppel-targeting antibodies
#419METHOD FOR EVALUATING STATE OF CELL DIFFERENTIATION
#420Polypeptide and use thereof
#421QUANTIFICATION OF BIOCONJUGATE GLYCOSYLATION
#422DATA COLLECTION METHOD TO BE USED FOR CLASSIFYING CANCER LIFE
#423URINARY EXOSOME BIOMARKER FOR DIAGNOSING ANTIBODY-MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION OR PREDICTING PROGNOSIS OF PATIENT AFTER KIDNEY TRANSPLANTATION
#424Nucleic acid taggants
#425BISPECIFIC ANTI-CD37 ANTIBODIES, MONOCLONAL ANTI-CD37 ANTIBODIES AND METHODS OF USE THEREOF
#426METHOD OF PREPARING A SAMPLE FOR A DIAGNOSTIC ASSAY
#427Anti-polyubiquitin multispecific antibodies
#428AFFINITY ISOLATION SYSTEM AND METHOD USING SWITCH-LIKE BINDING REACTION
#429BITTER TASTE RECEPTOR BLOCKERS AND METHODS OF THEIR IDENTIFICATION
#430Neuromodulation techniques
#431SYSTEMS AND METHODS FOR BIOMOLECULE PREPARATION
#432Process for Preparing Immunoglobulin Compositions
#433RECOMBINANT GLYCAN BINDING PROTEINS
#434Rapid assay for detection of SARS-CoV-2 antibodies
#435METHODS FOR STABLE COMPLEX FORMATION AND RELATED KITS
#436ZIPPER STRUCTURE THAT HELPS THE FORMATION OF PROTEIN DIMER AND APPLICATION THEREOF
#437DIAGNOSTIC FOR MATERNAL RISK OF HAVING A CHILD WITH AUTISM SPECTRUM DISORDER
#438Methods for categorizing and treating subjects having cystic fibrosis (CF) and at risk for severe pulmonary exacerbation
#439ANTIBODY BINDING TO PD-1
#440Methods of treating HLA-E-expressing cancers by administering antibodies which bind human natural killer cell inhibitory receptor group 2A (NKG2A)
#441POLYPEPTIDE MAGNETIC NANOPARTICLE, PREPARATION METHOD THEREFOR AND USE THEREOF
#442Nucleic acid molecules encoding antibodies which bind natural killer cell inhibitory receptor group 2A protein (NKG2A)
#443METHODS FOR OBTAINING ANTIBODIES THAT BIND TRANSMEMBRANE PROTEINS AND CELLS THAT PRODUCE THE SAME
#444DIAGNOSIS, PREVENTION, AND/OR TREATMENT OF AUTOIMMUNE DISEASES
#445Insect inhibitory proteins
#446In situ measurement of absolute concentrations by normalized Raman imaging
#447NOVEL ANTI-TROPONINT ANTIBODIES
#448MICROBIOME RESPONSE TO AGENTS
#449Prevention and treatment of diabetic nephropathy
#450Method for quantitative measurement of catechol estrogen bound protein in blood sample
#451Methods of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic disease
#452Anti-lag-3 antibody polypeptide
#453METHOD OF DETECTING THE PRESENCE OF A BIOMARKER IN A SAMPLE OF A FLOWABLE SUBSTANCE AND A DETECTOR ASSEMBLY FOR USE IN THE DETECTION OF THE BIOMARKER IN THE SAMPLE
#454PARTICLES, AFFINITY PARTICLES HAVING LIGAND FOR TARGET SUBSTANCE, IN VITRO DIAGNOSTIC REAGENT AND KIT THAT INCLUDE SAME, AND METHOD FOR DETECTING TARGET SUBSTANCE
#455KIT FOR DETECTING SOLUBLE GROWTH STIMULATION EXPRESSED GENE 2 PROTEIN
#456Humanized anti-DKK2 antibody and uses thereof
#457STABILIZED EXTRACELLULAR DOMAIN OF CD19
#458Conjugation reagents and methods using 1,2-cyclohexanediones
#459ANTI-CD6 ANTIBODY COMPOSITIONS AND METHODS FOR TREATING LUPUS
#460SYSTEMS AND METHODS USING NUCLEAR MAGNETIC RESONANCE (NMR) SPECTROSCOPY TO EVALUATE PAIN AND DEGENERATIVE PROPERTIES OF TISSUE
#461SYSTEM AND METHOD FOR PROVIDING NEOANTIGEN IMMUNOTHERAPY INFORMATION BY USING ARTIFICIAL-INTELLIGENCE-MODEL-BASED MOLECULAR DYNAMICS BIG DATA
#462NOVEL ANTI-PD-L1 ANTIBODY AND USES THEREOF
#463Bedbug detection, monitoring and control techniques
#464UTILIZATION OF BLOOD COMPONENT-CONTAINING SOLUTIONS FOR BIOPROSTHETIC VALVE MANUFACTURE AND TESTING
#465Protein binding domains stabilizing functional conformational states of GPCRS and uses thereof
#466BH4 Stabilized Peptides And Uses Thereof
#467Unstructured non-repetitive polypeptides having lcst behavior
#468DETECTION OF CEREBROSPINAL FLUID
#469DETECTING ELEMENTS USING SUGAR-LECTIN COUPLINGS
#470Identifying new therapeutic agents
#471Nanoscale biochemical sample preparation and analysis
#472Photoresponsive protein and utilization thereof
#473Application of ERH gene in the preparation of bladder cancer diagnosis and treatment products
#474X-aptamers for the use in detection of SNAP25
#475USE OF PROBDNF REGULATOR IN B CELL-RELATED DISEASES
#476CELLS AND METHODS FOR EVALUATING THE ACTIVITY OF ORGANIC ANION TRANSPORTING POLYPEPTIDE 2A1 (OATP2A1)
#477BIOMARKERS AND METHODS FOR MEASURING AND MONITORING AXIAL SPONDYLOARTHRITIS ACTIVITY
#478STRAIN PRODUCING ERGOTHIONEINE AND METHOD FOR SCREENING THE SAME
#479ANTIBODIES TO MISFOLDED TDP-43 AND METHODS OF USE
#480Genetically encoded biosensors
#481Peptide markers for authenticating Ejiao and related gelatins
#482Light-emitting body, method for producing light-emitting body, and biological material labeling agent
#483Reagents for detecting Alu elements in cell-free DNA (cfDNA)
#484In vivo methods for selecting peptides that cross the blood brain barrier, related compositions and methods of use
#485Protein melt analysis using dipyrrometheneboron difluoride compounds
#486Methods of screening
#487INFLAMMATION-ENABLING POLYPEPTIDES AND USES THEREOF
#488METHODS OF IDENTIFYING DRUG-MODULATED POLYPEPTIDE TARGETS FOR DEGRADATION
#489ANTI-LAP ANTIBODY VARIANTS AND USES THEREOF
#490Immunogenic compositions comprising polypeptides and fusions thereof
#491TRANSITION METAL CHELATING BEADS
#492KIDNEY DISEASE PROGNOSIS PREDICTION METHOD AND SYSTEM
#493Immunogenic antigen identification from a pathogen and correlation to clinical efficacy
#494SANDWICH-TYPE ASSAYS USING DECREASING SIGNAL PORTIONS OF DOSE RESPONSE CURVE TO MEASURE ANALYTES, INCLUDING ANALYTES AT HIGH CONCENTRATION
#495Compositions comprising stabilized oxygen and methods of forming the same
#496DETECTION AND TREATMENT OF IL-17 AND IL-13 RELATED CONDITIONS
#497SENSITIVE AND MULTIPLEXED DETECTION OF NUCLEIC ACIDS AND PROTEINS FOR LARGE SCALE SEROLOGICAL TESTING
#498Anti-B7-H3 monoclonal antibody and use thereof in cell therapy
#499INTER-ALPHA INHIBITOR PROTEINS AND METHODS OF USE THEREOF
#500FLUORESCENT PROBE AND PREPARATION METHOD AND USE THEREOF
#501Method for determination of members of the S100 family of calcium binding proteins by immunoturbidimetry
#502ANTIBODIES FOR TREATING MALIGNANT TUMORS AND USES THEREOF
#503METHODS AND REAGENTS FOR MULTIPLEX BINDING EXPERIMENTS
#504Fusion proteins comprising extracellular domain of human CD22
#505PEPTIDE COMPOSITION AND USES THEREOF
#506Methods of Treating an Autoimmune Disease with a Human Interleukin-3 (IL-3)-Diphtheria Toxin Conjugate (DT-IL3)
#507Method for structural analysis of organic compound
#508Detection chip, detection system, and detection method
#509METHODS AND KITS USING NUCLEIC ACID ENCODING AND/OR LABEL
#510Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof
#511COMBINATORIAL USE OF MARKERS TO ISOLATE SYNAPTIC GLIA TO GENERATE SYNAPSES IN A DISH FOR HIGH-THROUGHPUT AND HIGH-CONTENT DRUG DISCOVERY AND TESTING
#512SUBSTANCES, VACCINES AND METHODS FOR DIAGNOSING AND REDUCING INCIDENCES OF TRANSPLANT REJECTION
#513Compositions, Methods, and Systems for Detecting Methicillin-Resistant Staphylococcus Aureus
#514Immunoprobe-based method to assess organ injury status through a biofluid-based cell-free DNA (cfDNA) assay
#515Anti-polyubiquitin antibodies and methods of use
#516Artificial proteins and compositions and methods thereof
#517METHODS AND MATERIALS FOR LARGE-SCALE ASSESSMENT OF LIGAND BINDING SELECTIVITY OF G-QUADRUPLEX RECOGNITION USING CUSTOM G4 MICROARRAYS
#518Galectin-10 antibodies
#519METHODS FOR DIAGNOSING AND TREATING CANCERS
#520CD131 binding proteins and uses thereof
#521CHIMERIC MOLECULES
#522Accurate measurement of glutathione for disease diagnosis and drug metabolite screening
#523Methods for Sample Quality Assessment
#524A METAL-REDUCING ENZYMATIC TAG FOR OPTICAL AND ELECTRON MICROSCOPY
#525SAMPLING METHOD AND KIT FOR HISTAMINE MEASUREMENT
#526COMPOSITION FOR INHIBITING FCERI EXPRESSION AND METHOD FOR INHIBITING FCERI EXPRESSION
#527Fascin-2 (FSCN2) Variants And Uses Thereof
#528Methods of treating or preventing serious symptoms from COVID-19 infection
#529Microchip capillary electrophoresis assays and reagents
#530Methods and Compositions for Highly Sensitive Detection of Molecules
#531ASTROCYTE-DERIVED EXOSOME COMPLEMENT PROTEIN ASSAY FOR TRAUMATIC BRAIN INJURY AND METHODS AND AGENTS FOR TREATING TRAUMATIC BRAIN INJURY
#532COMPOSITIONS AND METHODS RELATING TO INHIBITORS OF PRO-INFLAMMATORY CYTOKINES AND CHEMOKINES FOR TREATMENT OF CANCER
#533METHODS OF DETECTION OF MECHANICALLY-ACTIVATED PLATELET ACTIVATION AND USES THEREOF
#534Stabilized minimal coiled-coil mimetics
#535SYSTEMS AND METHODS FOR ANALYZING PERSISTENT HOMEOSTATIC PERTURBATIONS
#536Method for coating a cell culture surface
#537Systems and methods for proteomic activity analysis using DNA-encoded probes
#538Anti-OX40 antibody
#539BISPECIFIC ANTIBODY AND USE THEREOF
#540Systems and methods for reducing lab-to-lab and/or instrument-to-instrument variability of multi-attribute method (MAM) by run-time signal
#541PREDICTION AND TREATMENT OF IMMUNOTHERAPEUTIC TOXICITY
#542METHOD FOR FULL-RANGE DETECTION OF C-REACTIVE PROTEIN AND CORRESPONDING KIT
#543SYSTEMS AND METHODS FOR MATCHING ONCOLOGY SIGNATURES
#544METHODS AND KITS FOR DETECTING MISFOLDED PROTEINS
#545MULTI-SAMPLE ARRAY CHIP FOR DNA MODIFICATION QUANTIFICATION
#546Photo-cleavable surfactants
#547ANTIBODY PAIRS FOR USE IN A RAPID INFLUENZA B DIAGNOSTIC TEST
#548Duty cycle improvement for a mass spectrometer using ion mobility separation
#549Compositions and methods for diagnosis and treatment of cancer
#550Methods and Systems for Measuring Plasma Renin Activity
#551Aptamer-Based Multiplexed Assays
#552Method for differentiation of ocular cells and use thereof
#553COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE
#554METHODS AND COMPOSITIONS FOR DETECTION AND QUANTIFICATION OF SMALL MOLECULES AND OTHER ANALYTES
#555Serum albumin-binding fibronectin type III domains
#556BIOMARKER PANEL FOR MONITORING KIDNEY HEALTH
#557Methods for treating heart disease in a subject with Friedreich's ataxia by an aromatic-cationic peptide
#558Method and System for Identifying and Classifying a Liver Condition in a Human Subject
#559ANTIHUMAN BAFF ANTIBODY
#560Methods of screening for condensate-associated specificity and uses thereof
#561REAGENT COMPOSITION FOR MEASURING GLYCATED ALBUMIN AND METHOD FOR MEASURING GLYCATED ALBUMIN USING SAME
#562Devices, Systems, and Methods for Aiding in the Detection of a Physiological Abnormality
#563Methods for stable complex formation and related kits
#564SYSTEMS AND METHODS OF OPTICALLY DETERMINING ANALYTE CONCENTRATIONS
#565FRAGMENTED GRS POLYPEPTIDE AND VARIANT THEREOF, AND USE THEREOF
#566METHOD FOR TREATING AUTOIMMUNE AND INFLAMMATORY DISEASES
#567Des-acyl ghrelin and analogs as cancer therapies
#568Peptoid, and its preparation method and use
#569COMPOSITION FOR PREVENTION OR TREATMENT OF INTRACTABLE EPILEPSY COMPRISING mTOR INHIBITOR
#570Non-antibody ligands for detecting target proteins
#571TEXTURED COMPOSITIONS, METHODS, AND SYSTEMS FOR RETAINING BIOMOLECULES
#572OVARIAN CANCER BIOMARKER AND METHODS OF USING SAME
#573G protein-coupled receptor (GPCR) ligand assay
#574THERAPEUTIC REGIMENS FOR CHIMERIC ANTIGEN RECEPTOR (CAR)- EXPRESSING CELLS
#575Evaluating method of ketosis in postpartum dairy cows
#576METHODS AND APPARATUS FOR CONDUCTING MULTIPLE MEASUREMENTS ON A SAMPLE
#577Novel Immune Checkpoint Inhibitors
#578TIM-3 antagonists for the treatment and diagnosis of cancers
#579Devices, methods, and kits for multiplexing a fluid sample via fluid sample reuse
#580METHOD FOR TREATING AUTOIMMUNE DISEASE
#581Soluble HLA class II complexes and methods of production and uses thereof
#582Polyspecificity reagents, methods for their preparation and use
#583COMPOSITIONS AND METHODS FOR DETECTING ALBUMIN
#584Devices, kits and methods for detecting misfolded proteins
#585Method for predicting efficacy of anti-PD-1 antibody or anti-PD-L1 antibody therapy, method for evaluating cancer grade, and method for enhancing efficacy of anti-PD-1 antibody or anti-PD-L1 antibody therapy
#586Method for detecting selenoamino acid in selenoprotein
#587ANTICANCER COMBINATION THERAPY WITH CD73 ANTAGONIST ANTIBODY AND PD-1/PD-L1 AXIS ANTAGONIST ANTIBODY
#588PREDICTION OF PREECLAMPSIA BASED ON IGFBP-7
#589Multiwell electrode-based biosensor
#590MARKERS OF TOTIPOTENCY AND METHODS OF USE
#591Streptavidin muteins and methods of using them
#592Biomarkers for Diagnosis and Prognosis of Corneal Ectatic Disorders
#593MATERIALS AND METHODS FOR DETECTING FUSION PROTEINS
#594ENGINEERED BACTERIA EXPRESSING RACEMASE FOR TREATING DISEASES ASSOCIATED WITH HYPERAMMONEMIA
#595Assay for FGF2 Secretion and Signaling
#596Brain-specific angiogenesis inhibitor 1 (BAI1) antibodies and uses thereof
#597Methods and materials for using biomarkers which predict susceptibility to clostridium difficile infection
#598Non-invasive prediction of risk for sudden cardiac death
#599Transgenic mouse for aglycosylated antibody production and use of aglycosylated antibody produced therefrom
#600Methods of treating spinal cord injury using a chondroitin sulfate proteoglycan (CSPG) reduction peptide (CRP) comprising a cell membrane penetrating domain, a CSPG binding domain, and a lysosome targeting domain